Mass Spec Sales Are Up in Q2; Waters Delays UPLC Shipments, ABI Nixes SPR | GenomeWeb

Mass spec sales were up for all three major instrument vendors that reported their earnings for the quarter this week, though sales for proteomics applications varied.

Applied Biosystems reported an increase of 40 percent in mass spec revenues for its fiscal fourth quarter ended June 30, compared to the same quarter last year, while Waters’ mass spec sales increased by 11 percent, excluding currency effects. Thermo Electron, which does not quantify its mass spec sales growth for competitive reasons, characterized them as “phenomenal.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.